Milestone Pharmaceuticals Inc. ($MIST)
Filing Information
| Accession Number | 0001910985-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Dec 12, 2025 |
| Document | View SEC Filing |
Transactions
6
Total Shares
310,452
Total Value
$158,209.09
P&L
+inf% (+$170,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Shares | โ | Dec 12, 2025 | Grant/Award | 100,000 | โ | โ | 163,333 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | Dec 15, 2025 | Sale | 58,007 | $2.32 | $134,576.24 | 105,326 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | Jan 26, 2026 | Exercise/Conversion | 20,100 | โ | โ | 125,426 | Direct | โ | View Details | |
Chief Medical Officer | Common Shares | โ | Jan 26, 2026 | Sale | 12,245 | $1.93 | $23,632.85 | 113,181 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Dec 12, 2025 | Grant/Award | 100,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
Chief Medical Officer | Restricted Stock Units | Derivative | Jan 26, 2026 | Exercise/Conversion | 20,100 | $0.00 | $0.00 | 60,300 | Direct | โ | View Details |